Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Luteinizing hormone (lhp); Follicle stimulating hormone (fshp); Luteinizing hormone (lhp); Follicle stimulating hormone (fshp)
LABORATORIOS CALIER S.A.
QG03GA
Luteinizing hormone (lhp); Follicle stimulating hormone (fshp); Luteinizing hormone (lhp); Follicle stimulating hormone (fshp)
50/50 international unit(s)/millilitre
Powder and solvent for solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
Cattle
Gonadotropins
Hormone
Authorised
2008-09-26
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Pluset powder and solvent for solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Powder and solvent for solution for injection. White to off-white lyophilised pellet and clear and colourless solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (reproductively mature females) 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES To induce superovulation in reproductively mature heifers or cows. 4.3 CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance or to any of the excipients. Do not use in males and reproductively immature female cattle. See section 4.7. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None One vial of lyophilized product contains: ACTIVE SUBSTANCES: Follicle stimulating hormone (FSHp) 500 IU Luteinizing hormone (LHp) 500 IU One vial of solvent contains: Chlorocresol 0.021 g Sterile, pyrogen-free, normal saline to 21 ml Each ml of reconstituted solution contains: ACTIVE SUBSTANCE Follicle stimulating hormone (FSHp) 50 IU Luteinizing hormone (LHp) 50 IU EXCIPIENTS Chlorocresol 1 mg Sterile, pyrogen-free, normal saline to 1 ml For a full list of excipients, see section 6.1 H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _3_ _1_ _/_ _0_ _5_ _/_ _2_ _0_ _1_ _6_ _C_ _R_ _N_ _ _ _7_ _0_ _2_ _3_ _3_ _0_ _6_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN AN Read the complete document